DnB Asset Management
RIGL icon

DnB Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

DnB Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,337
Closed -$502K – 647
2020
Q4 		$502K Sell
14,337
-296
-2% -$8.57K ﹤0.01% 604
2020
Q3 		$351K Sell
14,633
-234
-2% -$5.75K ﹤0.01% 599
2020
Q2 		$271K Buy
14,867
+511
+4% +$9.19K ﹤0.01% 596
2020
Q1 		$223K Hold
14,356
– – ﹤0.01% 606
2019
Q4 		$307K Buy
+14,356
New +$296K ﹤0.01% 633

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DnB Asset Management's RIGL Position: Q1 2021 in Review

DnB Asset Management sold out of Rigel Pharmaceuticals (RIGL) in Q1 2021, closing a stake of 14,337 shares — an estimated $502K sold.

DnB Asset Management first reported a position in RIGL in Q4 2019 and held it in 5 quarters. The position peaked at $502K in Q4 2020. 152 funds tracked by Wall St. Rank hold RIGL as of Q1 2021.

  • DnB Asset Management reported no remaining Rigel Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • DnB Asset Management sold 14,337 Rigel Pharmaceuticals shares in Q1 2021, an estimated $502K.
  • DnB Asset Management first reported a position in Rigel Pharmaceuticals in Q4 2019 and held it in 5 quarters.
  • DnB Asset Management's Rigel Pharmaceuticals position peaked at $502K in Q4 2020.
  • 152 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2021.

Based on DnB Asset Management's 13F filing for Q1 2021, filed 15 Apr 2021.